GGrantIndex
Sort

50,496 grants matching lung cancer

Clinical Laboratory Core

$764,901
Jennifer W Tidey · Brown University · P20 · FY2019 · GM

SurvivorCare: A digital health solution to support long-term cancer survivorship using patient navigation

$764,805
Y. Xian Ho · Dimagi, Inc. · R44 · FY2021 · CA

Integrated Molecular, Cellular, and Imaging Characterization of Screen-Detected Lung Cancer

$764,788
Steven M. Dubinett · University Of California Los Angeles · U01 · FY2017 · CA

A Percutaneous Ultrasound-Guided Catheter for Organ and Vascular Access

$764,687
Christopher Dykes · Perceptive Navigation, Llc · R42 · FY2016 · HL

Circulating metabolites as novel risk biomarkers for gastric cancer: a large multi-center prospective investigation

$764,565
Xiang Shu · Sloan-Kettering Inst Can Research · R37 · FY2024 · CA

Clinical Protocols in the Cancer Signaling Networks Section

$764,528
Udayan Guha · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Lung Cancer FAST (Fragment Analysis, SNP, and Translocations) Testing

$764,448
Justin T Brown · Cereus Diagnostics Corp. · R44 · FY2025 · CA

CCR5-mutant monkey model to facilitate the development of novel stem cell-based therapies for AIDS

$764,417
Igor I Slukvin · University Of Wisconsin-Madison · R24 · FY2016 · OD

Core G: Clinical Cohort and Comorbidity Research

$764,216
Mari M Kitahata · University Of Washington · P30 · FY2021 · AI

Risk prediction and longitudinal assessment of cardiotoxicity and functional capacity trajectory in NSCLC patients

$764,190
Zhongxing Liao · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · HL

Clonal hematopoiesis and inherited genetic variation in sickle cell disease

$764,009
Alexander Bick · Vanderbilt University Medical Center · R01 · FY2024 · HL

Missouri Valley Cancer Consortium CCOP

$763,999
Missouri Valley Cancer Consortium, Inc. · U10 · FY2003 · CA

NYU Lung Cancer Biomarker Center

$763,892
William N Rom · New York University School Of Medicine · U01 · FY2011 · CA

Characterization And Pharmacology Of Receptors For Gastrointestinal Peptides

$763,573
Robert Jensen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK

Cellular Basis Of Action Of Gastrointestinal Peptides/Growth factors

$763,573
Robert Jensen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK

Development of Drugs Acting at Adenosine Receptors

$763,518
Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK

Nanotechnology Platform for Targeting Solid Tumors

$763,442
Jan E Schnitzer · Sidney Kimmel Cancer Center · R01 · FY2008 · CA

Cohort Study of Cancer-Inhibitory Dietary Factors in Men

$763,145
Xiao-Ou Shu · Vanderbilt University · R01 · FY2011 · CA

POLYOMA HOST INTERACTIONS LEADING TO TUMOR DEVELOPMENT

$763,109
Harvard University (Medical School) · R01 · FY2004 · CA

Longitudinal Studies of HIV-Associated Lung Infections and Complications

$762,936
Kristina Anne Crothers · Yale University · R01 · FY2008 · HL

Mechanistic Risk Prediction of Radiation Therapy Cardiotoxicity

$762,918
Bonnie Ky · University Of Pennsylvania · R01 · FY2020 · HL

COLORECTAL CANCER (CRC) SCREENING VIA RECTAL NANOCYTOLOGY

$762,880
Hariharan Subramanian · Nanocytomics, Llc · R44 · FY2014 · CA

Winship National Clinical Trials Network Lead Academic Participating Site

$762,746
Nabil F Saba · Emory University · UG1 · FY2024 · CA

Biomolecular Recognition and Binding Mechanisms

$762,675
Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Prognostic Biomarker Development in Progressive Fibrosing Interstitial Lung Disease

$762,646
Justin M Oldham · University Of Michigan At Ann Arbor · R01 · FY2024 · HL